In patients undergoing transcoronary ablation for septal hypertrophy, concentrations of highsensitivity cardiac troponin T (hs-cTnT) 1 increase within 15 min 1 Nonstandard abbreviations: hs-cTnT; AMI, acute myocardial infarction; ACS, acute coronary syndrome; ED, emergency department; IQR, interquartile range; AUC, area under the ROC curve.
[2.60 (1.55) vs 1.21 (0.69) mmol/L, P ϭ 0.01]. Linear regression analyses identified a significant correlation of plasma D-lactate concentration with acidosis (bicarbonate, r ϭ Ϫ0.575, P Ͻ 0.001) and high anion gap (r ϭ 0.593, P Ͻ 0.001) (Fig. 1) . The contribution of D-lactate to acidosis and anion gap was comparable to that of ␤-hydroxybutyrate. The contribution of D-lactate and ␤-hydroxybutyrate to the high anion gap found in DKA was statistically significant (r ϭ 0.593, P Ͻ 0.001, and r ϭ 0.642, P Ͻ 0.001, respectively).
Under physiologic conditions, D-lactate is present in the human body at low concentrations (4 ) . Blood concentrations of D-lactate are increased in diabetes, and particularly in DKA in humans (3 ) . D-lactate is generated by degradation of methylglyoxal, an intermediate glucose metabolite, through the glyoxalase system (3, 5 ) . High concentrations of D-lactate can induce severe metabolic acidosis, resulting in neurological symptoms and encephalopathy. In hyperglycemic disorders such as diabetes mellitus and DKA, methylglyoxal production is greatly increased (3, 5 ) . Consistent with our previous finding, the increased D-lactate concentration is inversely associated with bicarbonate concentration and positively correlated with the increasing anion gap. Reduction of plasma D-lactate concentrations correlated well with improvement of bicarbonate concentrations and anion gap following treatment.
In conclusion, our findings suggest a large contribution of plasma D-lactate to the metabolic acidosis and high anion gap in DKA. Inclusion of the measurement of plasma D-lactate concentrations helps to account for the anion gap and the severity of metabolic acidosis in patients with DKA. Measurement of plasma D-lactate is important in predicting the severity of DKA as characterized by acidosis and high anion gap and monitoring DKA progression. 2, 3 ) . Moreover, the kinetics shown in those with septal ablation suggest that an even earlier evaluation might be possible for clinical decision-making (1, 2 ) . To assess the usefulness of early troponin measurements, we assessed the performance of hs-cTnT and hs-cTnI at 90 min and 3 h for predicting hospitalization for acute coronary syndrome (ACS) in patients presenting to the emergency department (ED) within 6 h of chest pain onset.
This study included patients enrolled in the RING study (Reducing the time Interval for identifying New Guideline defined MI in patients with suspected ACS in the ED; research ethics board approved) (4 ) who had EDTA plasma frozen (Ϫ80°C) at presentation (baseline), 90 min, and 3 h (n ϭ 130 patients). Inclusion criteria were: Ն18 years old with onset of ACS symptoms in the past 6 h, blood sample collection ordered by the ED physician for cardiac troponin measurement, informed consent obtained, and availability for telephone follow-up. We excluded patients presenting with ST-elevation myocardial infarction, those referred directly to surgery, trauma patients, and previously enrolled individuals. We followed all patients for 72 h to determine if an ACS hospitalization occurred (combined outcome of AMI or a hospitalization for unstable angina or refractory ischemic cardiac pain, defined as recurrent ischemic symptoms lasting 15 min or more, along with documented electrocardiographic changes indicative of ischemia or leading to a referral for an additional intervention such as thrombolytic therapy or cardiac catheterization or revascularization). An emergency physician and internal medicine specialist independently adjudicated all outcomes and were blinded to the hs-cTnT (lot #157120) and hscTnI results (Abbott ARCHITECT precommercial prototype assay measurement after second thaw). We used StatsDirect software for descriptive and nonparametric testing (Mann-Whitney, Friedman, and Conover testing) and Analyse-it software for ROC analyses. A P value of Ͻ0.05 was considered significant.
The median [interquartile range (IQR)] age of the study cohort was 60 years (50 -71 years) with 64% (n ϭ 83) males. Of the 130 patients enrolled, there were 14 patients hospitalized for ACS (n ϭ 8 AMI diagnosed with cTnT fourth generation, n ϭ 6 unstable angina or refractory ischemic cardiac pain). There was no difference in age between the ACS and non-ACS groups of patients [59 years Using ROC curve analysis to assess the discrimination of ACS patients (n ϭ 14) and non-ACS patients (n ϭ 116), we observed that 3-h measurements were superior to 90-min measurements (Fig. 1.) [hs-cTnT 3 The absolute ␦ at 3 h which gave a positive likelihood ratio of 10 (to rule in) for hscTnT was Ն9 ng/L and for hscTnI was Ն28 ng/L These data suggest that the performance of measurements at 3 h for both hs-cTnT and hs-cTnI is superior to measurements at 90 min. The use of earlier decision points such as 90 min may not be prudent, because a 3-h measurement for the high-sensitivity cardiac troponin assays will still be necessary in most patients. The 3-h time-point for hs-cTnT has recently been reported as equivalent to the 6-h timeframe (3 ) . Whether this will also apply for hs-cTnI remains to be determined, because that assay is more sensitive than the hs-cTnT assay (5 ). Larger prospective studies will be required to validate the 0 -3-h evaluation period and the ␦ for high-sensitivity cardiac troponin assays with respect to both diagnostic and prognostic outcomes in patients presenting to the ED early after the onset chest pain. 
